Telehealth ADHD Prescribing: What Psychiatric NPs Can Do in California

If you’re a psychiatrist wondering whether you can prescribe Adderall, Vyvanse, or other ADHD medications through telehealth — or a PMHNP trying to understand your scope — here’s the straight answer: Yes, psychiatrists can currently prescribe ADHD stimulants via telehealth, but the rules are in flux and vary significantly by state.

Let’s cut through the regulatory confusion and talk about what you can actually do in your practice right now, what’s changing, and how different states treat ADHD prescribing authority for MDs versus NPs.

The Federal Framework: Where Things Stand in 2026

The elephant in the room is the Ryan Haight Act, the 2008 federal law that normally requires an in-person medical evaluation before prescribing Schedule II controlled substances (which includes most ADHD medications).

During the COVID-19 pandemic, the DEA waived this requirement, allowing psychiatrists to initiate stimulant prescriptions entirely via video visit. That flexibility has been extended through December 31, 2025 — the third such extension. As of early 2026, we’re in a grey area: the extension bought time, but unless Congress acts or the DEA issues permanent rules, the in-person requirement could snap back into place.

What this means for your practice: Right now, you can start a new ADHD patient on Adderall or Ritalin through a comprehensive video evaluation without ever seeing them in person. But you need a contingency plan — partnering with local clinics for in-person exams, hybrid workflows, or focusing on patients you can see occasionally in person — in case regulations revert.

The DEA has discussed creating a special telemedicine registration that would allow controlled substance prescribing without in-person visits, but nothing concrete has been finalized. Keep an eye on DEA rulemaking in 2026.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What Psychiatrists Can Do: Clinical Capabilities via Telehealth

From a clinical standpoint, psychiatrists can manage the entire ADHD treatment episode through telehealth:

• Diagnosis: Conduct comprehensive psychiatric evaluations via video, using clinical interviews, standardized rating scales (ADHD-RS, ASRS), and collateral information from family or schools. A mental status exam focusing on attention, impulse control, and executive function translates well to video.

• Prescribing: Write e-prescriptions for stimulants (Adderall, Vyvanse, Ritalin, Concerta) or non-stimulants (Strattera, Wellbutrin, Intuniv) through DEA-compliant EPCS platforms. Most telehealth platforms have this built in.

• Monitoring: Follow-up visits to assess symptom response, side effects, and medication adjustments work perfectly via video. You can ask patients to self-report vitals (many adult ADHD patients now own blood pressure cuffs) or coordinate with their PCP for periodic checks.

• Ongoing management: Monthly medication checks, typical for Schedule II stimulants (no refills allowed — each month requires a new prescription), are straightforward 15-minute video appointments.

What you can’t do remotely: Administer long-acting injectable medications (not relevant for ADHD) or conduct hands-on physical exams. But ADHD diagnosis and medication management don’t require those.

The real constraints aren’t clinical — they’re regulatory and state-specific.

State-by-State Rules: Where You Can Prescribe and Under What Conditions

State telehealth laws add another layer. Some states explicitly welcome telehealth prescribing for psychiatric conditions; others are silent and default to federal rules. Here’s what matters in six major markets:

Florida: Explicitly Allows Psychiatric Telehealth Prescribing

Florida statute 456.47 carves out a clear exception: providers can prescribe Schedule II controlled substances via telehealth for psychiatric disorders (among other specific conditions like hospice). ADHD qualifies.

If you’re a Florida-licensed psychiatrist, you can start and manage ADHD stimulant therapy entirely through video visits. Florida also requires checking the state’s E-FORCSE prescription monitoring program before prescribing controlled substances and mandates e-prescribing (no paper scripts for stimulants).

For PMHNPs in Florida: You need a collaborative protocol with a psychiatrist. Florida limits nurse practitioners to a 7-day supply of Schedule II drugs — except for ‘psychiatric nurses’ (PMHNPs with a master’s degree working under a psychiatrist’s protocol). In that case, you can prescribe the standard 30-day supply. You still need physician oversight, but you’re not handcuffed to weekly prescriptions.

Texas: Physicians Only for Outpatient ADHD Stimulants

Texas allows telehealth prescribing for mental health conditions via live video, but here’s the catch for NPs: Texas law prohibits nurse practitioners from prescribing Schedule II controlled substances in outpatient settings except in hospitals, hospice, or emergency departments.

Translation: If you’re a PMHNP in Texas treating outpatient ADHD via telehealth, you cannot write Adderall prescriptions. Only physicians (psychiatrists, family docs) can. NPs need a supervising physician, and even with that, state law bars them from outpatient Schedule II prescribing.

For psychiatrists in Texas: You have full authority. You can prescribe stimulants through telehealth to any patient in Texas (as long as you’re Texas-licensed). Given that Texas ranks 43rd nationally in psychiatrist supply (roughly 1 psychiatrist per 9,000 residents), demand is massive. Telehealth lets you serve patients across the state’s 254 counties, many of which have no local psychiatric prescriber.

Texas also doesn’t require PDMP checks specifically for stimulants (unlike for opioids), though checking is best practice.

California: Transitioning to NP Independence

California is phasing in nurse practitioner autonomy through AB 890. Experienced NPs (≥3 years, 4,600 hours of practice) can now apply for independent practice authority (‘104 NP’ status), allowing them to prescribe Schedule II medications without physician supervision.

Until an NP achieves that status, they work under standardized procedures with physician oversight. All California NPs prescribing Schedule II drugs must complete a controlled substances pharmacology course.

For psychiatrists: You have unrestricted authority. California follows federal telehealth rules (no additional state barriers), so as long as the DEA waiver is active, you can prescribe ADHD meds via video. California mandates e-prescribing for all controlled substances, which means your platform must support EPCS.

Market note: California has nearly 8,000 psychiatrists but also 40 million people. Urban areas are competitive; rural Central Valley and Inland Empire are underserved. Telehealth lets you tap into both markets.

New York: NP Independence After 3,600 Hours

New York grants full practice authority to nurse practitioners after they complete 3,600 hours (roughly 2 years) of supervised practice. During that period, they need a written collaborative agreement with a physician. After that, they can practice and prescribe all medications — including Schedule II stimulants — independently.

For psychiatrists: Unrestricted prescribing authority. New York has no state-level telehealth restrictions on controlled substances. However, New York mandates PDMP checks for every Schedule II prescription and requires e-prescribing for all controlled substances.

New York ranks 4th nationally in psychiatrist density (about 1 per 2,900 residents), largely due to NYC’s concentration of providers. But upstate New York has significant shortages. Telehealth allows urban psychiatrists to serve rural communities remotely.

Pennsylvania: NPs Have Quantity Limits

Pennsylvania requires all nurse practitioners to work under a collaborative agreement with a physician. For Schedule II prescribing, PA law limits NPs to:

• 72-hour supply for initial prescriptions (new patient or new condition)
• 30-day supply for ongoing therapy, with the collaborating physician reviewing the case before continuation

For psychiatrists: No limits. You can prescribe 30-day supplies (or use sequential prescriptions for 90-day coverage) as standard. Pennsylvania follows federal telehealth policy — no extra state restrictions — but hasn’t passed comprehensive telehealth legislation yet.

Practical workflow in PA: Many practices have the psychiatrist write the first stimulant prescription (avoiding the 72-hour NP limit), then the NP handles follow-up refills under the collaborative agreement.

Pennsylvania has moderate psychiatrist supply in Philadelphia and Pittsburgh but shortages in rural areas. Telehealth can fill those gaps if you’re PA-licensed.

Illinois: Moving Toward NP Independence

Illinois allows nurse practitioners to obtain Full Practice Authority after completing 4,000 hours of clinical practice plus 250 hours of additional training. Once granted, NPs can prescribe Schedule II medications without a collaborative agreement (though Illinois requires a physician consultation relationship specifically for Schedule II narcotics/opioids — this doesn’t apply to ADHD stimulants).

Before achieving FPA, NPs must have a written collaborative agreement that explicitly delegates prescriptive authority for controlled substances.

For psychiatrists: Full independent authority. Illinois has strong telehealth parity laws and no unique restrictions on controlled substance prescribing via telemedicine. The state mandates e-prescribing for all controlled substances as of 2023.

Illinois has moderate psychiatrist supply (1 per ~5,800 residents), concentrated in Chicago. Downstate Illinois has significant shortages, creating opportunity for telehealth providers.

Reimbursement: You’ll Get Paid for Telehealth ADHD Care

One major concern for providers: Will insurance actually pay for virtual medication management?

Yes. As of 2026, telehealth reimbursement parity is nearly universal for mental health services. Private insurers and Medicare pay the same rates for telehealth visits as in-person visits (48 states have parity laws or widespread insurer adoption).

Medicare rates for common ADHD medication management visits:

• 90792 (initial psychiatric evaluation with medical services): ~$188–$202
• 99213 (15-minute established patient visit): ~$89–$95
• 99214 (25-minute moderate complexity visit): ~$125–$136

Commercial insurance typically pays equal to or higher than Medicare — often 10-30% more depending on the plan. Medicaid pays less (roughly $40–$65 for a 15-minute med check), but Medicaid patients often have the least access to in-person care, making telehealth critical.

Psychiatrists are reimbursed at the highest levels for psychiatric services compared to other provider types. If you’re billing under your own NPI as an MD/DO, you get full physician rates. Some NPs get paid at 85% of physician rates under Medicare if billing independently (though many platforms structure billing to maximize reimbursement).

Telehealth visits use standard CPT codes with a telehealth modifier or place-of-service code. As long as you document properly (patient location, consent, standard of care via video), claims process like any other psychiatric visit.

The Economics: Why ADHD Telehealth Makes Sense (Without Inflating Patient Acquisition Costs)

Let’s talk business reality. If you’re considering telehealth, you’re probably wondering: Can I actually build a sustainable practice, or is this just another saturated market?

The demand is real. ADHD prescriptions surged during the pandemic as adults sought help via newly accessible online care, and that demand hasn’t slowed. Medication shortages (Adderall backorders in 2023-2024) and long waitlists for in-person psychiatrists mean patients are actively looking for telehealth providers.

But here’s the catch many providers don’t talk about: acquiring psychiatric patients is expensive.

If you’re starting your own practice and trying to market yourself, here’s what you’re facing:

• Google Ads for mental health keywords run $15–$40+ per click. Most clicks don’t convert. By the time you factor in testing ad creative, managing campaigns, and actually getting someone to book (and show up), you’re looking at $200–$400+ per booked patient in acquisition costs.

• SEO (organic search rankings) takes 6–12 months of consistent content creation, backlink building, and technical optimization before you see meaningful patient flow. You’ll spend thousands on an agency or consultant before your first organic patient books.

• Directory listings (Psychology Today, Zocdoc, Therapy Den) charge monthly fees to list you alongside hundreds of competitors. Zocdoc charges per booking ($35–$100+), but you’re also paying the monthly subscription. Add it all up, and you’re spending $200–$500 per new patient by the time you factor in all the clicks, subscriptions, and failed campaigns.

• No-shows and unqualified leads from DIY marketing can hit 30-40%. That cold Google click might not even be someone appropriate for your services.

If you have deep pockets and can wait 6-12 months to ramp up, DIY marketing can eventually work. But for most providers — especially those starting out or scaling — that upfront investment and uncertainty is a major barrier.

This is where a platform like Klarity Health makes economic sense.

Instead of gambling $3,000–$5,000/month on marketing with no guarantee of results, Klarity uses a pay-per-appointment model. You pay a standard listing fee only when a pre-qualified patient books with you. No upfront ad spend. No monthly subscription fees hoping someone finds you in a crowded directory. No wasted clicks on people who aren’t actually ready to start ADHD treatment.

Klarity pre-qualifies patients, matches them to your specialty and availability, and handles the entire patient acquisition funnel. You get both insurance-credentialed and cash-pay patient flow. The platform includes built-in telehealth infrastructure (no need to pay separately for a video platform, EHR, or e-prescribing system). And you control your schedule — you only pay when you actually see patients.

That’s guaranteed ROI versus rolling the dice on whether your SEO investment will pay off 9 months from now.

For psychiatrists in restrictive states like Texas or Florida (where NPs can’t fully prescribe ADHD meds independently), your MD credential is especially valuable. Platforms need physicians to serve those markets, which gives you leverage.

ADHD Prescribing Best Practices for Telehealth

Given increased scrutiny of online ADHD prescribing (remember the Done Health scandal that led to federal investigations?), you need to practice defensively:

1. Conduct thorough evaluations: Use DSM-5 criteria, standardized rating scales, and obtain collateral information when appropriate (especially for pediatric cases). Document everything. A 10-minute video chat isn’t sufficient for initiating stimulant therapy.

2. Verify patient identity and location: Confirm the patient’s state (for licensure compliance) and identity at each visit. Most platforms handle this, but it’s your responsibility.

3. Check the Prescription Drug Monitoring Program (PDMP): Many states mandate PDMP checks before prescribing controlled substances. Even where it’s not mandatory for stimulants, it’s smart practice to spot red flags (multiple overlapping prescriptions, doctor shopping).

4. Coordinate with primary care when needed: For older adults or patients with cardiac history, consider requesting a baseline EKG or blood pressure check through their PCP. You can manage ADHD via telehealth while still ensuring appropriate medical oversight.

5. Use treatment agreements and informed consent: Document discussions about risks of stimulant therapy, potential for misuse, and expectations for follow-up. Some providers use written patient agreements.

6. Schedule regular follow-ups: Monthly visits are standard for stimulant management (since Schedule II drugs require a new prescription each month). This also lets you monitor for side effects and adherence.

7. Be prepared for medication shortages: Adderall and other stimulants have been backordered periodically since 2022. Know your alternatives (non-stimulants, different stimulant formulations) and have a plan to help patients navigate pharmacy shortages.

Pain Points Providers Face with ADHD Telehealth (And How to Navigate Them)

Regulatory uncertainty: The DEA’s temporary waivers make long-term planning difficult. Until there’s a permanent rule or law, you’re practicing under extensions. Mitigation: Build flexibility into your practice model (hybrid in-person/telehealth, partnerships with local clinics).

State-by-state complexity: If you’re licensed in multiple states, you’re juggling different NP collaboration rules, PDMP requirements, and prescribing limits. Mitigation: Use decision support tools (many platforms provide state-specific compliance checklists) and stay current on board regulations.

Medication shortages: Your patients will be frustrated when Adderall is backordered. You’ll spend extra time coordinating alternative pharmacies or medications. Mitigation: Educate patients upfront about potential supply issues and have backup medication options ready.

High patient volume and brief visits: Telehealth platforms can fill your schedule quickly, but ADHD medication management requires careful monitoring. Don’t fall into the trap of running a pill mill. Mitigation: Set realistic appointment lengths (15-20 minutes for established patients, 45-60 minutes for intakes) and limit your daily patient load to what you can safely manage.

Liability concerns: Overprescribing scandals have put telehealth ADHD providers under scrutiny. Mitigation: Practice conservatively, document thoroughly, and avoid red-flag behaviors (prescribing to patients you’ve never seen, ignoring signs of diversion, skipping PDMP checks).

Why Psychiatrists Are Critical (Especially in Restricted States)

If you’re a psychiatrist, your MD/DO credential gives you maximum flexibility and authority across all states. You don’t need supervision, you’re not limited to 7-day or 72-hour prescription quantities, and you can practice independently from day one.

In states like Texas and Florida where NPs face significant restrictions on ADHD prescribing, psychiatrists are the only providers who can fully manage outpatient stimulant therapy. This makes you indispensable to telehealth platforms trying to serve those markets.

Even in NP-friendly states like New York or Illinois, psychiatrists often handle complex cases, provide supervision to early-career NPs, and manage patients with comorbidities (ADHD + bipolar, ADHD + substance use) that require more nuanced medication management.

You’re also reimbursed at the highest rates, making the economics of your practice more favorable. A psychiatrist seeing 16 patients/day at $125/visit (99214 rate) grosses $2,000/day, $40,000/month with a full schedule. Remove the overhead of traditional office space (telehealth from home) and you’re looking at strong net income.

PMHNPs: Know Your State’s Rules Before You Start

If you’re a psychiatric nurse practitioner, your ability to prescribe ADHD medications depends entirely on your state:

• Full practice authority states (NY after 3,600 hrs, IL with 4,000 hrs + FPA, CA with 104 NP status): You can practice like a psychiatrist once you meet the requirements.

• Collaborative agreement states with reasonable limits (PA, FL with psychiatric nurse exception): You can prescribe ADHD meds but need physician oversight and may have initial quantity restrictions.

• Restricted states (TX): You’re limited to non-stimulant ADHD medications or must work in a team model where the psychiatrist writes the stimulant prescriptions.

Before joining a telehealth platform, clarify:

• Will they provide a collaborating physician if your state requires one?
• What’s the physician-to-NP ratio cap in your state, and how many NPs is your collaborator already overseeing?
• Are there additional credentialing or protocol requirements?

Many platforms (like Klarity) handle these logistics, pairing NPs with supervising physicians in restricted states so you can focus on patient care.

FAQ: ADHD Telehealth Prescribing

Can psychiatrists prescribe Adderall through telehealth in 2026?
Yes, currently through the end of 2025 under DEA temporary waivers extended for the third time. As of early 2026, the policy is still in effect but awaiting permanent resolution. Check for updates on federal telehealth rules.

Do I need to see an ADHD patient in person before prescribing stimulants?
Not under current federal waivers (through Dec 31, 2025). If the Ryan Haight Act’s in-person requirement returns, yes — you’d need at least one in-person medical evaluation before prescribing Schedule II controlled substances via telemedicine.

Can PMHNPs prescribe ADHD medications via telehealth?
It depends on the state. In full practice authority states (after meeting experience requirements), yes. In restricted states like Texas, no — NPs cannot prescribe Schedule II stimulants for outpatient ADHD. In collaborative practice states, NPs can prescribe under physician oversight, sometimes with quantity limits.

What’s the difference between PMHNP and psychiatrist prescribing authority for ADHD?
Psychiatrists (MD/DO) have unrestricted authority in all 50 states. PMHNPs’ authority varies by state: some states grant full independence, others require physician collaboration, and a few prohibit NP prescribing of Schedule II drugs entirely.

Will insurance cover telehealth ADHD medication management?
Yes. Nearly 48 states have telehealth parity laws or insurer policies paying equal rates for telehealth and in-person mental health visits. Medicare and most commercial plans cover telepsychiatry at the same reimbursement levels.

Which states are hardest for ADHD prescribers to practice in?
Texas (NPs cannot prescribe outpatient Schedule II stimulants), Georgia (NPs cannot prescribe Schedule II at all), and states with pending regulatory uncertainty. States like New York, Illinois, and California (for experienced NPs) are most permissive.

How do I check if a patient is doctor shopping for stimulants?
Use your state’s Prescription Drug Monitoring Program (PDMP). Many states require PDMP checks before prescribing controlled substances. Look for overlapping prescriptions, multiple prescribers, or patterns consistent with diversion.

Can I prescribe ADHD medications across state lines via telehealth?
Only if you’re licensed in the state where the patient is physically located at the time of the appointment. You need a medical license in each state you practice in. Some states participate in interstate compacts (like the Interstate Medical Licensure Compact) to streamline multi-state licensing.

What happens if the DEA in-person requirement comes back?
You’d need to conduct at least one in-person exam before initiating Schedule II controlled substance prescriptions via telemedicine. You could continue treating existing telehealth patients with stimulants (grandfathered), but new patients would require an in-person visit first. Many providers would adopt hybrid models or partner with local clinics.

Is there high demand for telehealth ADHD services?
Yes. Adult ADHD diagnosis and treatment surged during the pandemic and remains high. Many areas have months-long waitlists for in-person psychiatry. Medication shortages (Adderall backorders) have also increased demand for providers who can help navigate alternatives.

Ready to Start Treating ADHD Patients via Telehealth?

If you’re a psychiatrist or PMHNP looking to expand into telehealth ADHD care, the opportunity is real — but so are the regulatory complexities.

Klarity Health offers a straightforward path: pre-qualified ADHD patients matched to your availability, a pay-per-appointment model that eliminates upfront marketing risk, built-in compliance infrastructure (EPCS, EHR, credentialing support), and both insurance and cash-pay patient flow.

For psychiatrists, especially in states like Texas, Florida, and Pennsylvania where your MD credential is essential for ADHD prescribing, joining a platform gives you immediate patient access without the months-long SEO ramp or expensive ad campaigns.

For PMHNPs in full practice or collaborative states, Klarity can pair you with supervising physicians (where needed) and handle the administrative complexity of multi-state practice.

[Explore joining Klarity’s provider network →]

Sources and Verification

The information in this guide is based on current federal and state regulations, industry data, and news sources as of February 2026. Key sources include:

Federal Telehealth Policy:

• Axios News – ‘COVID-era telehealth prescribing extended again’ (Nov 18, 2024): Confirms DEA/HHS extended temporary waivers for controlled substance prescribing via telehealth through December 31, 2025.
• Axios News – ‘Telehealth prescribing mess could reach Congress’ (Sept 18, 2024): Details the ongoing policy uncertainty around Ryan Haight Act waivers and potential expiration.

State Scope of Practice & Prescribing Rules:

• RxAgent ‘NP Prescriptive Authority by State (2026 Guide)’ (Updated Dec 28, 2025): Comprehensive state-by-state comparison of nurse practitioner prescribing authority, including Schedule II limits, collaboration requirements, and recent legislative changes.
• Florida Statutes §456.47 (2023): Official state law explicitly allowing telehealth prescribing of Schedule II controlled substances for psychiatric disorders.
• Florida Statutes §464.012 (2025): Defines APRN prescribing limits (7-day rule) and psychiatric nurse exception for psychotropic controlled substances.
• Texas SB 2527 Bill Analysis (88th Legislature, April 2023): Texas legislative analysis documenting concerns about inappropriate telehealth stimulant prescribing and state regulatory approach.
• CCHP (Center for Connected Health Policy) – Texas State Telehealth Laws (Updated Jan 19, 2026): Details Texas telemedicine rules for controlled substance prescribing and chronic pain restrictions.
• Pennsylvania Code – 49 Pa. Code §21.284: Official regulation detailing CRNP prescribing limits (72-hour initial, 30-day ongoing for Schedule II).
• Illinois Nurse Practice Act – 225 ILCS 65: Illinois law establishing Full Practice Authority pathway for NPs (4,000 hours + 250 hours training requirement).

Reimbursement & Economic Data:

• Therathink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (Updated 2026): CPT code reimbursement data for Medicare, Medicaid, and commercial insurers covering psychiatric medication management.
• BehaveHealth – ‘Mental Health Reimbursement Trends – Telehealth Parity 2026’ (2024): Analysis of telehealth parity adoption across states.

Provider Supply & Market Conditions:

• Healing Psychiatry Florida Blog – ‘Psychiatrist Shortage by State – 2026 Report’ (Jan 15, 2026): State-by-state psychiatrist-to-population ratios and shortage area designations.
• Texas Tribune – ‘Texas’ shortage of mental health care professionals is getting worse’ (Feb 21, 2023): Data on psychiatrist supply and mental health workforce shortages in Texas.

ADHD Treatment Trends & Medication Shortages:

• Associated Press – ‘More adults sought help for ADHD during pandemic…’ (Jan 10, 2024): Reports surge in ADHD prescriptions during COVID-19 and ongoing medication shortages.
• Axios Vitals Newsletter – various health policy briefs (2023-2024): Coverage of DEA production limits for ADHD medications and telehealth policy debates.

All regulatory claims have been verified against official state statutes or authoritative secondary sources. Information reflects the regulatory environment as of February 2026, with awareness that federal telehealth controlled substance prescribing rules are subject to change pending DEA rulemaking or Congressional action in 2026.

Source:

• https://www.axios.com/2024/09/18/telehealth-services-controlled-substances-congress#:~:text=Why%20it%20matters%3A%20Pandemic,end%20of%20this%20year%20after
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,the%20third%20temporary%20extension%20of
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=1,disorder
• https://rxagent.co/blog/np-prescribing-authority#:~:text=OK%20%20,day%20%28ongoing%29%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=TN%20%20,NP%3A%20Independent%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=match%20at%20L210%20NY%20,terminal%20illness%2C%20MD%20initiation
• https://rxagent.co/blog/np-prescribing-authority#:~:text=ID%20%20,3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=FL%20%20,NP%3A%20Independent%20%5B3
• https://www.leg.state.fl.us/STATUTeS/index.cfm?Appmode=DisplayStatute&Search_String=&URL=0400-0499%2F0464%2FSections%2F0464.012.html#:~:text=also%20limit%20the%20prescribing%20of,shall%20adopt%20by%20rule%20the